Tritylolmesartan medoxomil (CAS No: 144690-92-6) is a key pharmaceutical intermediate used in the synthesis of APIs Olmesartan medoxomil. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Triphenyl methyl olmesartan, Olmesartan Impurity 12
CAS No: 144690-92-6
PubChem CID: 19036162
Mol Formula: C48H44N6O6
Mol Weight: 800.9 g/mol
Used in API: Olmesartan medoxomil
IUPAC Name: (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
API Intermediate Description: Trityl Olmesartan Medoxomil isn't the drug you take; it's a key intermediate chemical (a "prodrug") used in the manufacture and synthesis of the actual medicine, Olmesartan Medoxomil, which is an Angiotensin II Receptor Blocker (ARB) used to treat high blood pressure (hypertension) in adults and children by relaxing blood vessels. Think of it as a protected form of the active drug, which gets converted in the body. Its uses are in pharmaceutical research, quality control, and as a reference standard for testing, not for direct patient consumption.
